Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...

In a report released today, Harsh Kumar from Piper Sandler maintained a Buy rating on Semtech (SMTC – Research Report), with a price target of ...

Larson Financial Group LLC increased its stake in shares of HubSpot, Inc. (NYSE:HUBS – Free Report) by 168.8% in the fourth ...

By Ravichandran Venkataraman In 1945, humanity split the atom, unleashing boundless energy and existential fear. Today, in ...

It announced on Thursday that Robert Marrocco, formerly global head of ETP, or exchange-traded products, listings at Cboe ...

Josh Hug co-founded Remitly in 2011 and served as chief product officer until 2016 when he took on the chief operating ...

Mitchell says that AI’s corporate leaders bring “different levels of their own human concerns and thoughts” to these ...

Oppenheimer reiterates a Perform rating on Cartesian Therapeutics (RNAC) without a price target following the company’s Q4 report. The ...

Showtime has cast David Dastmalchian ( Oppenheimer) in Dexter: Resurrection in the guest starring role of “Gareth.” ...

The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one being that he was one of the top bulls on Wall Street. (Oppenheimer as of ...

Managing Director - Investments CFP The Summa Group of Oppenheimer & Co. Inc. Asset/Investment Management ...

Daniel Haskel of the lab’s Photon Sciences directorate has been selected to represent Argonne in the 2025 cohort of DOE’s ...